THC pain study for endometriosis pulled before start
NCT ID NCT06834997
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a synthetic THC pill (Marinol) could safely reduce chronic pelvic pain in women with endometriosis. It planned to enroll up to 75 women aged 18-64 and give them THC or a placebo for 8 weeks. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
Hosuton, Texas, 77030, United States
-
Michael E DeBakey VA Medical Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can yoga ease the pain of endometriosis after surgery?
- Building a biological treasure trove to decode Women's health mysteries
- Gaming for health: could a video game empower endometriosis patients?
- Can a new formulation of an endometriosis drug match the standard?
- Can a glowing dye reveal a Woman's fertility after ovarian cyst surgery?
- Can we predict endometriosis recurrence and fertility outcomes?